10
Dec 2025
How the human brain processes spoken language mirrors AI architecture
A new study reveals that the human brain processes spoken language in a sequence that closely mirrors the layered architecture of advanced AI language models.
Stay Informed!
10
Dec 2025
Study provides new insights into brain signaling during sleep and wakefulness
An international team led by the University of Michigan has introduced new methods that reveal which regions of the brain were active throughout the day with single-cell resolution.
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "Two ongoing studies show promise of pivekimab sunirine in treating aggressive blood cancers")
10
Dec 2025
Two ongoing studies show promise of pivekimab sunirine in treating aggressive blood cancers
Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of pivekimab sunirine (PVEK), an antibody-drug conjugate targeting CD123, in treating two aggressive blood cancers at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
10
Dec 2025
Analysis of Alzheimer's disease and related dementias uncovers disparities in Maryland's rural communities
A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in Maryland's rural communities, offering a striking example of how healthcare accessibility is shaping health outcomes across the United States.
10
Dec 2025
Contraception and surgical sterilization associated with increased life expectancy
Blocking reproduction increases lifespan in both males and females of many different species, a new international University of Otago – Ōtākou Whakaihu Waka-led study has found.
10
Dec 2025
Addition of tucatinib to the standard of care delays disease progression in HER2-positive metastatic breast cancer
Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, potentially extending time off chemotherapy, according to results from the phase III clinical trial HER2CLIMB-05 presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
10
Dec 2025
Next-generation oral SERD therapy lowers the risk of breast cancer recurrence
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy for early-stage (1-3) hormone receptor (HR)-positive, HER2-negative breast cancer, significantly lowered the risk of the disease returning when compared with standard hormone therapies long considered the backbone of treatment.
10
Dec 2025
Machine learning models can help diagnose ALS earlier from a blood sample
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests.
10
Dec 2025
Triaptosis could be a promising strategy in the fight against cancer
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens while limiting gains in human life expectancy.
10
Dec 2025
Study shines new light on how cancer avoids the mitotic stopwatch pathway
When cell division (mitosis) takes too long, it can be a sign that something is wrong with the cells, for example DNA damage or chromosomal instability.
